HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Psychiatry
Sys. Review
Propranolol shows potential for managing various neurological diseases including PTSD, migraine, and autism spectrum disorder
Propranolol Shows Promise for Brain Conditions
This systematic review synthesizes clinical and preclinical evidence regarding the effects of propranolol on several neurological conditions…
A new review suggests propranolol, a common blood pressure drug, may help with PTSD, autism, and more. Here's what it means.
Frontiers
Aug 17, 2026
Rheumatology
Sys. Review
R-(+)-propranolol targets SOX18 for anti-hemangioma effect independent of beta-blockade
New insights into how specific medicine types treat infant hemangioma growth
This systematic review examines the mechanism of R-(+)-propranolol in infantile hemangioma. It identifies SOX18 as the core molecular target…
A new review shows that one specific form of propranolol may target and shrink baby hemangiomas through a unique pathway.
Frontiers
Jul 30, 2026
Oncology
Sys. Review
Oral propranolol remains the primary systemic treatment for infantile hemangioma with no superior alternatives
Propranolol Remains the Standard Treatment for Infantile Hemangioma
This meta-analysis of 2639 patients found that no active intervention, including corticosteroids or other beta-blockers, demonstrated statis…
A review of over 2,600 cases shows that while several drugs treat infantile hemangioma, oral propranolol remains a primary standard.
Jul 23, 2026
Pediatrics
Sys. Review
Propranolol and propafenone provide stable management for CALM2 mutation related LQTS/CPVT overlap in children
New findings on managing heart rhythm issues in children
This case report describes the clinical outcomes of two Chinese children with CALM2 mutation-related LQTS/CPVT overlap. One patient remained…
Two cases of rare genetic heart conditions show how different medications can have very different effects on a child's safety.
Frontiers
Jul 23, 2026
Pediatrics
Meta-analysis
30% of pediatric patients with migraine report at least one adverse event during pharmacological prophylaxis
Trial Shows Specific Side Effects for Children with Migraine
This meta-analysis of 2742 patients evaluates the safety profile of various pharmacological migraine prophylaxis treatments in children and …
About 30% of children and adolescents taking migraine prevention medication report experiencing at least one side effect during treatment.
Jul 8, 2026
Drug Pipeline
RCT
Perioperative Propranolol and Etodolac Safety and 8-Year Survival in Cancer Patients
Safe Drug Combo May Help Cancer Patients Heal Faster
This randomized controlled trial evaluated perioperative propranolol and etodolac in 148 patients with breast, colorectal, and pancreatic ca…
A safe drug mix of propranolol and etodolac helps breast, colorectal, and pancreatic cancer patients heal faster after surgery without causi…
Frontiers
Apr 20, 2026
Gastroenterology
Meta-analysis
Network meta-analysis compares preventive measures for esophageal variceal bleeding in 6510 cirrhosis patients
New Combo Stops Bleeding Better Than Old Drugs
This network meta-analysis synthesizes data from 6510 patients with liver cirrhosis and esophageal varices regarding primary preventive meas…
Combining two specific medicines stops dangerous stomach bleeding better than older single-drug treatments for people with advanced liver sc…
Frontiers
Apr 16, 2026